In addition, signaling pathway inhibitors and activators or FOXO1 gene knockdown were used to clarify the function of the PI3K/AKT signaling pathway and FOXO1 in Gypenoside XLIX protection against stroke. The gene discussed is AKT1; the disease is stroke disorder.